8
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Novel Methods in Vascular and Lymphatic Physiology

      Submit here before June 30, 2025

      About Journal of Vascular Research: 1.8 Impact Factor I 3.4 CiteScore I 0.486 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Does the Extent of the Zone at Risk after Coronary Artery Occlusion Influence the Percentage of the Zone that Evolves to Infarction?

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To examine whether the extent of the zone at risk for infarction after coronary artery occlusion influences the percentage of the zone that evolves to necrosis in the absence of intervention, <sup>99m</sup>Tc-labeled albumin microspheres were injected into the left atrium 1 min after coronary occlusion in 34 dogs. Six hours after occlusion, the left ventricle was cut into 3-mm-thick slices for triphenyltetrazolium chloride staining and autoradiography. The extent of myocardial necrosis and hypoperfused zone was measured by planimetry and expressed as a percentage of the total volume of the left ventricle. The extent of myocardial necrosis and hypoperfused zone varied widely from 8 to 40% and 14 to 43% of the left ventricle, respectively. However, there was a close correlation between infarct size (IS, percent of left ventricle) and the extent of hypoperfused zone (HZ, percent of left ventricle): IS = 0.89x (HZ) – 0.21 (r = 0.909, SEE = 3.02, p < 0.01). The ratio of infarct size to the extent of hypoperfused zone was 87.9 ± 2.3%. Dogs with large hypoperfused zones (≧ 30% of the left ventricle) had a significantly greater ratio of infarct size to the extent of the hypoperfused zone (95.3 ± 2.4%, n = 11, p < 0.05) than dogs with small hypoperfused zones ( < 30% of the left ventricle; 84.3 ± 3.0%, n = 23). Moreover, the ratio was ≧ 90% in all but one dog (91 %) with large hypoperfused zones, but in only 10 of 23 dogs (43%) with small hypoperfused zones (p < 0.05). Thus, the extent of hypoperfused zone was a major determinant of infarct size after coronary artery occlusion. The extent of the zone at risk for infarction after coronary occlusion also influenced the percentage of the zone with necrosis.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1990
          1990
          12 November 2008
          : 77
          : 2
          : 112-120
          Affiliations
          First Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
          Article
          174591 Cardiology 1990;77:112–120
          10.1159/000174591
          2397488
          4e3c5372-1a41-4788-a620-9507e2a90bfe
          © 1990 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 04 October 1989
          : 18 January 1990
          Page count
          Pages: 9
          Categories
          Original Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Autoradiography,Hypoperfused zone,Infarct size,Area at risk,Coronary artery occlusion

          Comments

          Comment on this article